PAPER Pitel AL, Chanraud S, Sullivan EV, Pfefferbaum A
SEARCH RESULTS
331259 RESULTS
PAPER Petzold A, Verwey NA, Van Uffelen K, Blankenstein MA, Teunissen C
Batch prepared protein standards for cerebrospinal fluid (CSF) biomarkers for neurodegeneration.
J Neurosci Methods. 2010 Nov 30;193(2):296-9. PubMed: 20832428PAPER Wolk DA, Dickerson BC,
Fractionating verbal episodic memory in Alzheimer's disease.
Neuroimage. 2011 Jan 15;54(2):1530-9. PubMed: 20832485PAPER Vemuri P, Weigand SD, Knopman DS, Kantarci K, Boeve BF, Petersen RC, Jack CR
Time-to-event voxel-based techniques to assess regional atrophy associated with MCI risk of progression to AD.
Neuroimage. 2011 Jan 15;54(2):985-91. PubMed: 20832487PAPER Swaab DF, Bao AM
(Re-)activation of neurons in aging and dementia: lessons from the hypothalamus.
Exp Gerontol. 2011 Feb-Mar;46(2-3):178-84. PubMed: 20833237PAPER Gunn AP, Masters CL, Cherny RA
Pyroglutamate-Aβ: Role in the natural history of Alzheimer's disease.
Int J Biochem Cell Biol. 2010 Dec;42(12):1915-8. PubMed: 20833262PAPER Selvi BR, Cassel JC, Kundu TK, Boutillier AL
Tuning acetylation levels with HAT activators: therapeutic strategy in neurodegenerative diseases.
Biochim Biophys Acta. 2010 Oct-Dec;1799(10-12):840-53. PubMed: 20833281PAPER Andrawis JP, Hwang KS, Green AE, Kotlerman J, Elashoff D, Morra JH, Cummings JL, Toga AW, Thompson PM, Apostolova LG
Effects of ApoE4 and maternal history of dementia on hippocampal atrophy.
Neurobiol Aging. 2010 Sep 10; PubMed: 20833446PAPER Figueiró M, Ilha J, Pochmann D, Porciúncula LO, Xavier LL, Achaval M, Nunes DS, Elisabetsky E
Acetylcholinesterase inhibition in cognition-relevant brain areas of mice treated with a nootropic Amazonian herbal (Marapuama).
Phytomedicine. 2010 Oct;17(12):956-62. PubMed: 20833520PAPER Ridgway GR
Clinical syndromes associated with posterior atrophy: early age at onset AD spectrum.
Neurology. 2010 Aug 3;75(5):479; author reply 479-80. PubMed: 20679643PAPER Austrom MG
Recruitment and retention: challenges and opportunities for the NIA funded Alzheimer Disease Centers Program. Introduction.
Alzheimer Dis Assoc Disord. 2010 Jul-Sep;24 Suppl:S1. PubMed: 20802260PAPER Sui R, Zhang L
Depression, Parkinson disease, Alzheimer disease. The homocysteine hypothesis.
Neurosciences (Riyadh). 2010 Jul;15(3):211-3. PubMed: 20831034PAPER Timmer NM, Herbert MK, Kleinovink JW, Kiliaan AJ, de Waal RM, Verbeek MM
Limited expression of heparan sulphate proteoglycans associated with Aβ deposits in the APPswe/PS1dE9 mouse model for Alzheimer's disease.
Neuropathol Appl Neurobiol. 2010 Oct;36(6):478-86. PubMed: 20831743PAPER Hort J, O'Brien JT, Gainotti G, Pirttila T, Popescu BO, Rektorova I, Sorbi S, Scheltens P,
EFNS guidelines for the diagnosis and management of Alzheimer's disease.
Eur J Neurol. 2010 Oct;17(10):1236-48. PubMed: 20831773PAPER Yaguchi T, Nagata T, Nishizaki T
1,2-dilinoleoyl-sn-glycero-3-phosphoethanolamine ameliorates age-related spatial memory deterioration by preventing neuronal cell death.
Behav Brain Funct. 2010;6:52. PubMed: 20831835Current Filters
No filters selected